Liver Disease Stocks List

Liver Disease Stocks Recent News

Date Stock Title
May 3 GILD The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine
May 2 GILD Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More
May 2 TARA Protara Therapeutics GAAP EPS of -$0.97
May 2 TARA Protara Therapeutics Announces First Quarter 2024 Financial Results and Provides Business Update
May 2 NTLA Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2024 Earnings and Company Updates
May 1 MIRM Mirum Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024
Apr 30 ALGS Aligos Therapeutics to Announce 1st Quarter 2024 Financial Results on May 7, 2024
Apr 30 GILD Gilead Sciences, Inc. (NASDAQ:GILD) Q1 2024 Earnings Call Transcript
Apr 30 MIRM Halozyme Therapeutics (HALO) Earnings Expected to Grow: Should You Buy?
Apr 29 GRI GRI Bio Announces Abstracts Accepted for Presentation at the 14th International Congress on Autoimmunity
Apr 29 NTLA Intellia Therapeutics to Present Updated Data from Phase 1/2 Study of NTLA-2002 for the Treatment of Hereditary Angioedema (HAE) at the EAACI Congress 2024
Apr 29 GILD Gilead expands FDA label for Biktarvy with Phase I pregnant HIV patient data
Apr 29 GILD Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
Apr 27 GILD Gilead Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Apr 27 GYRE Public companies are Gyre Therapeutics, Inc.'s (NASDAQ:GYRE) biggest owners and were rewarded after market cap rose by US$137m last week
Apr 26 GILD Gilead Sciences declares $0.77 dividend
Apr 26 GILD Gilead (GILD) Q1 Loss Narrower Than Expected, Sales Beat
Liver Disease

Liver disease (also called hepatic disease) is a type of damage to or disease of the liver. Whenever the course of the problem lasts long, chronic liver disease ensues.

Browse All Tags